The 20th Hebei (Spring) Medical Equipment Exhibition has been held in Shijiazhuang for 19 consecutive years. After years of continuous innovation and self-improvement, it has achieved a good reputation and practical results. It is planned to invite the heads of ICU departments of intensive care, surgery, anesthesiology, rehabilitation, ultrasound, imaging, and laboratory departments, distributors, agents, and end consumers from various hospitals in Hebei to attend more than 30,000 people. Hebei Medical Expo strives to become a brand exhibition in the medical industry that affects Hebei and radiates North China.

time：April 16-18, 2021

Place：Shijiazhuang International Expo Center (City Center/East Avenue 3)

Booth：No. 550 on the second floor

During the exhibition, Ningbo Aocheng will bring its latest product-Placental Growth Factor (PLGF) testing reagents and innovative solutions to the exhibition, and we sincerely invite you to visit.

Ningbo Aocheng Biotechnology Co., Ltd.'s new test product-Placental Growth Factor (PLGF) Test Kit-obtained the "Practical Guide for Early Preeclampsia Screening and Prevention in Early Pregnancy" issued by the International Federation of Obstetrics and Gynecology (FIGO) in 2019 and In 2020, the “Guidelines for the Diagnosis and Treatment of Hypertension in Pregnancy” issued by the Obstetrics and Gynecology Branch of the Chinese Medical Association’s “Guidelines for the Diagnosis and Treatment of Hypertension in Pregnancy” is the strongest level recommendation, opening a new chapter in the scientific and standardized management of hypertension and preeclampsia in pregnancy in my country.

Ningbo Aocheng Biotechnology Co., Ltd. is a high-tech biological enterprise focusing on the early detection, diagnosis, prevention and monitoring of diseases. By providing reliable, fast and convenient in vitro diagnostic products, it can provide accurate test results for diagnosis and treatment.

At present, the company's biomedical team continues to conduct in-depth exploration and prospective research in the field of high-risk diseases for pregnant women such as hypertension. We will be committed to providing leading clinical diagnosis solutions for maternal and child health. Promote the standardized management of perinatal preeclampsia in my country, and contribute to the predictive management of preeclampsia in the world.